Sublingual Misoprostol tablets versus intracervical dinoprostone for cervical ripening
Phase 4
- Conditions
- Health Condition 1: O80- Encounter for full-term uncomplicated delivery
- Registration Number
- CTRI/2021/05/033662
- Lead Sponsor
- RamyaA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Single term pregnancies ( >37 weeks of gestational age)
Live fetus â??Cephalic presentation.
Reassuring fetal heart rate tracing.
Pre-induction Bishopâ??s score of less than 6
Exclusion Criteria
Previous uterine scars.
Estimated fetal weight on scan greater than 4
Amniotic fluid Index less than 5 cm.
Fetal malformations.
Any contraindication to vaginal delivery like placenta previa Contracted pelvis, Cephalopelvic disproportion
Significant fetal or maternal comorbidities like severe pre- eclampsia or IUGR with doppler changes
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the time taken for cervical ripening between sublingual misoprostol tablets and intracervical dinoprostone gel.Timepoint: To compare the time taken for cervical ripening between sublingual misoprostol tablets and intracervical dinoprostone gel. At baseline ,1 st group every 4 hours max 6 doses,2 nd group every 6 hours max 4 doses
- Secondary Outcome Measures
Name Time Method To estimate the cumulative dose required in each group. <br/ ><br>To evaluate the feto-maternal outcome in both groups. <br/ ><br>Timepoint: Calculate total dose in 24 hours